scorecardresearch
Saturday, September 13, 2025
TopicDilip Shanghvi

Topic: Dilip Shanghvi

Sun Pharmaceuticals undergoes SEBI-ordered forensic audit

The latest probe points to challenges for India’s biggest drugmaker after whistle-blower complaints on corporate governance lapses triggered a stock slide last year.

Dilip Shanghvi of Sun Pharmaceutical’s to keep stake in Suzlon Energy despite falling value

In 2015, billionaire Dilip Shanghvi bought 23% stake for Rs 18 billion, but Suzlon still hasn’t exited India’s debt-restructuring program, missing deadlines since 2017.

On Camera

The key difference between India and China’s response to Gen-Z protests in Nepal

China is desperate to keep Communist Nepal ally intact. India must worry.

What’s behind bond yields’ logic-defying spike? The market’s concern over the future

While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.

Navy gets first Tata-made Spanish 3D surveillance radar for its warships, 19 more to come

It is one of the most advanced long-range air defence and anti-missile radars. It has been acquired under an about USD 145-million deal signed in 2020.

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?